SCHEMBL2849980

SCHEMBL2849980

CC(C)(C)OC(=O)N1CCC(C(=O)O)CC1.Nc1ccc(F)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.54
MEN1 O00255 1/20 0.54
PTPN2 P17706 1/20 0.51
PTPN1 P18031 1/20 0.51
PTPN6 P29350 1/20 0.51
MMP13 P45452 1/20 0.49
GPR119 Q8TDV5 2/20 0.49
ALDH1A1 P00352 2/20 0.48
NPC1 O15118 1/20 0.48
MAPT P10636 1/20 0.48
MAPK1 P28482 1/20 0.48
HTT P42858 1/20 0.48
RAB9A P51151 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
HSD17B10 Q99714 1/20 0.48
HPGD P15428 1/20 0.48
STS P08842 3/20 0.47
HDAC1 Q13547 1/20 0.47
HDAC2 Q92769 1/20 0.47
RECQL P46063 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2849977 0.88 GPR119 (0.61) KMT2AMEN1PTPN2PTPN1PTPN6
SCHEMBL43357 0.82 HPGD (0.66) KMT2APTPN2PTPN1PTPN6GPR119
SCHEMBL228921 0.81 HSD11B1 (0.63) KMT2AMEN1ALDH1A1
SCHEMBL24833605 0.81 MGLL (0.56) KMT2APTPN2PTPN1PTPN6GPR119
Acetic Acid SCHEMBL7381337 0.79 HPGD (0.62) KMT2APTPN2PTPN1PTPN6GPR119
SCHEMBL28455754 0.79 PTPN1 (0.81) KMT2AMEN1PTPN2PTPN1PTPN6
SCHEMBL21088061 0.79 KMT2A (0.54) KMT2APTPN2PTPN1PTPN6GPR119
SCHEMBL3073527 0.78 GPR119 (0.65) KMT2AMEN1MMP13GPR119ALDH1A1
SCHEMBL18805528 0.78 NAMPT (0.60) KMT2AMEN1MMP13GPR119MAPT
SCHEMBL270733 0.78 NAMPT (0.60) PTPN2PTPN1PTPN6GPR119ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7790725-B2 Thiazolidine derivatives and medicinal use thereof MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-09-07 US disclosed
US-20070259880-A1 THIAZOLIDINE DERIVATIVES AND MEDICINAL USE THEREOF MITSUBISHI PHARMA CORPORATION (JP) 2007-11-08 US disclosed
US-20040259883-A1 Thiazolidine derivative and medicinal use thereof MITSUBISHI PHARMA CORPORATION (JP) 2004-12-23 US disclosed
EP-1426366-A1 THIAZOLIDINE DERIVATIVE AND MEDICINAL USE THEREOF Mitsubishi Pharma Corporation (JP) 2004-06-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070259880-A1 THIAZOLIDINE DERIVATIVES AND MEDICINAL USE THEREOF DPP4, DPP7, DPP3 KMT2A 1595/4885MEN1 3295/4885PTPN2 112/4885
US-20040259883-A1 Thiazolidine derivative and medicinal use thereof DPP4, DPP7, DPP3 KMT2A 1883/4885MEN1 2196/4885PTPN2 149/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.